Vera Therapeutics, Inc.
VERA
$28.82
-$0.48-1.64%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 6.88% | -38.34% | -18.76% | -10.63% | -27.61% |
| Total Depreciation and Amortization | 129.17% | -98.39% | 201.77% | -36,825.00% | -33.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.36% | 199.92% | -72.27% | 79.74% | 27.57% |
| Change in Net Operating Assets | -112.42% | -4.57% | 171.28% | -315.37% | 57.64% |
| Cash from Operations | -6.23% | -48.84% | 26.75% | -34.55% | -9.45% |
| Capital Expenditure | -171.01% | -167.42% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -672.53% | 270.69% | 89.70% | -1,277.75% | 14.73% |
| Cash from Investing | -677.77% | 268.97% | 89.66% | -1,281.75% | 14.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 46,084.97% | -78.13% | -98.83% | 338,303.45% | -70.71% |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | 44,007.58% | -78.51% | -98.76% | 1,013.82% | 8,259.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,911.98% | 104.93% | -287.93% | 28.42% | 382.88% |
